Thanks, Vijay. We delivered an exceptional performance in the first quarter as we continue to maintain our focus and deliver on our stated objectives. Our strong results were driven by robust organic growth from cross-selling momentum and expanding customer relationships, along with the positive contributions from our highly accretive M&A activities in the prior year. Moving to our revenue performance. Our first quarter revenue increased to a first quarter record of $177.8 million, a 14.5% increase, compared to $155.3 million in the prior year period. The primary drivers of growth in the first quarter were strong organic growth in our Remediation and Reuse and Measurement and Analysis segments, plus contributions from acquisitions. Partially offset by a reduction in Assessment, Permitting and Response segment revenue due to several larger projects in the prior year period that did not repeat, and lower environmental emergency response revenues. The consolidated revenue increase resulted in our highest ever first quarter consolidated adjusted EBITDA of $19 million, a 12.5% increase, compared to $16.9 million in the prior year period. Consolidated adjusted EBITDA as a percent of revenue in the current year quarter was 10.7%, compared to 10.9% in the prior year period. The 20 basis point difference was associated with normalized project margins in the AP&R segment, offset by improved operating leverage in the M&A segment, and the benefit of acquisitions in 2024. I’ll note that despite being lower in Q1, full year 2025 consolidated adjusted EBITDA as a percentage of revenue is expected to be above full year 2024 due to operating leverage in our Measurement and Analysis segment and continued margin improvement in the Remediation and Reuse segment. In the first quarter of 2025, diluted adjusted net income per share was $0.07, compared to $0.16 in the prior year period. This was primarily due to higher interest and tax expenses and a higher weighted average diluted outstanding share count in the current quarter, partially offset by improved operating income before non-cash items. Please note that our adjusted net income per diluted share attributable to common stockholders is calculated using adjusted net income attributable to stockholders divided by fully diluted shares. We believe this net income methodology is the most helpful net income metric for Montrose and common equity investors. I will now discuss our first quarter performance by segment. In our Assessment, Permitting and Response segment, first quarter revenue was $53.1 million, compared to $58.6 million in the prior year period. AP&R segment adjusted EBITDA was $10.6 million or 19.9% of revenue, compared to 27.8% in the prior year period. Prior year results included several larger high margin projects that did not repeat in the current year and approximately $2 million lower emergency response revenue, which were partially offset by a $3 million contribution from an acquisition in 2024. Revenue and EBITDA comparisons normalized in subsequent quarters, and accordingly, we expect AP&R revenue and adjusted EBITDA to be up year-over-year in the remaining quarters of the year. We expect long-term and 2025 AP&R segment adjusted EBITDA margins to remain within a normalized 20% to 25% range. Turning to our Measurement and Analysis segment, revenue for the quarter increased 29.8% to $59 million. We continue to experience strong organic growth across lab and field services in addition to contributions from an acquisition in 2024. M&A segment adjusted EBITDA increased to $13.7 million or 23.3% of revenue, a 900-basis-point margin improvement over the prior year period due to operating leverage across all business lines driven by significantly higher revenue and contributions from an acquisition in 2024. We expect long-term M&A segment adjusted EBITDA margins to remain within a normalized 18% to 22% range, with 2025 annual segment margins expected to remain elevated above the high end of the range, primarily due to business mix, project timing and contributions from acquisitions. In our Remediation and Reuse segment, first quarter revenue increased 28.2% to $65.7 million, benefiting from strong organic growth in treatment technology revenue and contributions from acquisitions in 2024 of $5.1 million. This segment’s adjusted EBITDA increased to $5.9 million, though adjusted EBITDA margin declined 80 basis points to 9%, primarily driven by business line mix, in part driven by Q1 seasonality in our Canadian operations. We expect long-term R&R segment adjusted EBITDA margins to be within a 20% to 25% range, and are confident that R&R segment adjusted EBITDA margin will deliver year-over-year improvement for the balance of this year. Moving to our cash flow and capital structure. We achieved our highest ever first quarter net cash provided by operating activities of $5.5 million, compared to net cash used in operating activities of $22 million in the prior year period. The significant $27.5 million increase related to improvements in working capital primarily accounts receivable and contract assets. I am pleased to report that we are on track to significantly outperform 2024 and expect to achieve cash flow from operations greater than 50% of consolidated adjusted EBITDA in 2025. We were also pleased with the strength of our balance sheet at quarter end, reporting a leverage ratio of 2.2 times and substantial liquidity of $294.2 million, following the refinancing of our senior credit facility in Q1, which, as you recall, is larger and on more favorable terms than the previous credit facility. Last quarter, we provided an update on the previously disclosed delayed receivables from a large project related to a U.S. Navy-owned facility fire for the city of Tustin, California. As of yesterday, the remaining amount Tustin owes Montrose is approximately $7.5 million, compared to $13.5 million as reported in February of this year, with the difference of $6 million being collected after the first quarter end, and therefore was not included in the reported first quarter operating cash flow. We continue working collaboratively with Tustin and remain confident in the full collectability of the outstanding balance. Subsequent to quarter end, we redeemed $60 million of the Series A-2 Preferred Stock in cash, funded with cash on hand and borrowings under our credit facility. In the near-term, we will continue to prioritize balance sheet simplification through the redemption of the remaining Series A-2 Preferred Stock and subsequent deleveraging, while balancing potential stock repurchases. Optimizing our capital structure and leverage are integral parts of our strategy to maximize our financial flexibility. Looking forward, we will be measured in how we allocate capital to stock repurchases, investments to drive organic growth and future M&A, which remains a core part of our long-term growth story. Overall, we are very pleased with the momentum across our business and our strong start to the year. We remain focused on our strategic objectives to enhance our margin profile, generate strong cash flows and continue to simplify our capital structure through the redemption of the remaining $62 million of our outstanding preferred stock. Our increased guidance for the year reflects the confidence in our ability to continue driving value in our business and the many tailwinds we see. Thank you all for joining us today and for your continued interest in Montrose. We look forward to the opportunities we see ahead and updating you on our progress next quarter. Operator, we are ready to open the lines to questions.